1887

11 : Cryptosporidium parvum: Minuscule but Mighty

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Cryptosporidium parvum: Minuscule but Mighty, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816971/9781555811976_Chap11-1.gif /docserver/preview/fulltext/10.1128/9781555816971/9781555811976_Chap11-2.gif

Abstract:

This chapter demonstrates the power of tiny parasite to alter human health. It focuses on recent observations and highlights current areas of uncertainty. Regardless of the exact taxonomy of species, numerous studies now indicate that isolates exhibit considerable molecular heterogeneity. A study by researchers indicates that bovine genotype isolates do have variable virulence for humans and makes it perfectly clear that is a very infectious parasite. In this study, healthy human volunteers serologically negative for anti- antibodies were infected with one of three bovine genotype isolates. Studies of waterborne disease, children in developing countries, and AIDS patients as well as data examining the course of infection in healthy volunteers illustrate the complexity of clinical cryptosporidiosis. The understanding of the mechanisms by which infection stimulates intestinal secretion to cause diarrheal disease remains incomplete. However, a variety of observations have facilitated one's ability to develop a working model of disease pathogenesis due to . Only effective highly active antiretroviral therapy has been clearly shown to result in the resolution of disease in AIDS patients due to improved host immune function.

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Acid-fast stain of stool containing C. parvum or Cyclospora cayetanensis. This figure illustrates the size difference between the oocysts of C. parvum (left panel) and C. cayetanensis (right panel), which are approximately 5 and 10 µm, respectively. Magnification, ×436.

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2.
Figure 2.

Proposed phylogeny of C. parvum species. A recent proposal based on neighbor-joining analysis of small-subunit rRNA sequences of C. parvum and other proposed Cryptosporidium species suggests that closely related strains from humans, monkeys, calves, mice, guinea pigs (c. wrairi), geese (c. meleagridis), and cats (c. felis) be considered a C. parvum group. Of interest, C. felis has recently been identified in AIDS patients. Adapted from reference .

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3.
Figure 3.

C. parvum infection predicts enhanced diarrheal disease morbidity in children infected when less than 1 year of age. (A) Distribution over time of the post-Co parvum infection diarrheal disease burden in children who acquired C. parvum infection when less than 1 year of age. After C. parvurn infection, case children experienced a significant increase in diarrheal disease burden lasting 21 months in comparison with age-matched controls. *, P < 0.005; §, P < 0.03 for cases versus controls. (B) Similar data for children who acquired C. parvum infection when older than 1 year of age. In these older children, any excess diarrheal disease burden after the C. parvurn infection episode resolved within 6 months. The episode of C. parvurn- related diarrhea lasted a mean of 8.8 ± 1.8 days in the children younger than 1 year of age and 8.0 ± 1.8 days in children older than 1 year of age at time of first infection and is included in the 3-month time point on both panels. Reproduced from reference 2 with permission.

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4.
Figure 4.

Model of pathogenesis of diarrheal disease caused by C. parvum. Adhesion and invasion of C. parvum sporozoites and merozoites to the apical membrane of intestinal epithelial cells appear to stimulate the activity of several cellular kinases which participate in the cytoskeletal rearrangement associated with C. parvum invasion of the cell. Cellular invasion also stimulates the intestinal epithelial cells to produce prostaglandin synthase, interleukin-8 and tumor necrosis factor alpha. Recruitment of polymorphonuclear leukocytes (by interleukin-8), activation of macrophages (by tumor necrosis factor alpha), production of prostaglandins (by prostaglandin synthase), and alteration in the function of ion transporters (by cellular kinases) would be predicted to stimulate intestinal secretion in response to cellular infection with C. parvum. A subset of cells infected by C. parvum appear to undergo apoptotic cell death, also likely contributing to the pathophysiology of the disease. Abbreviations: PGE2, 12, prostaglandins E2 and I22 ; PMNs, polymorphonuclear leukocytes; MacroØ, macrophages; ENS, enteric nervous system. See tcxt for references.

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816971.chap11
1. Adams, R. B.,, R. L. Guerrant,, S. Zu,, G. Fang,, and J. K. Roche. 1994. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Infect. Dis. 169: 170 177.
2. Agnew, D. G.,, A. A. Lima,, R. D. Newman,, T. Wuhib,, R. D. Moore,, R. L. Guerrant,, and C. L. Sears. 1998. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J. Infect. Dis. 177: 754 760.
3. Aguirre, S. A.,, L. E. Perryman,, W. C. Davis,, and T. C. McGuire. 1998. lL-4 protects adult C57BLl6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. J. Immunol. 161: 1891 1900.
4.Anonymous. 1995. Assessing the public health threat associated with waterborne cryptosporidiosis: report of a workshop. Morb. Mortal. Wkly. Rep. CDC Surveill. Summ. 44: 119.
5. Blagburn, B. L.,, K. L. Drain,, T. M. Land,, R. G. Kinard,, P. H. Moore,, D. S. Lindsay,, D. A. Patrick,, D. W. Boykin,, and R. R. Tidwell. 1998. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42: 2877 2882.
6. Blanshard, C.,, A. M. Jackson,, D. C. Shanson,, N. Francis,, and B. G. Gazzard. 1992. Cryptosporidiosis in HIV-seropositive patients. Q. J. Med. 85: 813 823.
7. Carr, A.,, D. Marriott,, A. Field,, E. Vasak,, and D. A. Cooper. 1998. Treatment of HIV-l-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 351: 256 261.
8. Chai, J. Y.,, S. M. Guk,, H. K. Han,, and C. K. Yun. 1999. Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvum. J. Parasitol. 85: 234 239.
9. Chappell, C. L.,, P. C. Okhuysen,, C. R. Sterling,, C. Wang,, W. Jakubowski,, and H. L. DuPont. 1999. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am. J. Trop. Med. Hyg. 60: 157 164.
10. Checkley, W.,, L. D. Epstein,, R. H. Gilman,, R. E. Black,, L. Cabrera,, and C. R. Sterling. 1998. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am. J. Epidemiol. 148: 497 506.
11. Chen, W.,, J. A. Harp,, and A. G. Harmsen. 1993. Requirements for CD4~ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect. Immun. 61: 3928 3932.
12. Chen, X. M.,, S. A. Levine. P. Tietz, E. Krueger, M. A. McNiven, D. M. Jefferson, M. Mahle, and N. F. LaRusso. 1998. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 28: 906 913.
13. Clark, D. P. 1999. New insights into human cryptosporidiosis. Clin. Microbiol. Rev. 12: 554 563.
14. Clark, D. P.,, and C. L. Sears. 1996. The pathogenesis of cryptosporidiosis. Parasitol. Today 12: 221 225.
15. Colford, J. M., Jr.,, I. B. Tager,, A. M. mrozawa,, G. F. Lemp,, T. Aragon,, and C. Petersen. 1996. Cryptosporidiosis among patients infected with human immunodeficiency virus: factors related to symptomatic infection and survival. Am. J. Epidemiol. 144: 807 816.
16. Di Giovanni, G. D.,, F. H. Hashemi,, N. J. Shaw,, F. A. Abrams,, M. W. LeChevallier,, and M. Abbaszadegan. 1999. Detection of infectious Cryptosporidium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated cell culture-PCR. Appl. Environ. Microbiol. 65: 3427 3432.
17. DuPont, H. L.,, C. L. Chappell,, C. R. Sterling,, P. C. Okhuysen,, J. B. Rose. and W. Jakubowski. 1995. The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J. Med. 332: 855 859.
18. Elliott, D. A.,, and D. P. Clark. 2000. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect. Immun. 68: 2315 2322.
19. Flanigan, T.,, C. Whalen,, J. Thrner,, R. Soave. J. Toerner, D. Havlir, and D. Kotler. 1992. Cryptosporidium infection and CD4 counts. Ann. Intern. Med. 116: 840 842.
20. Forney, J. R.,, D. B. DeWald,, S. Yang,, C. A. Speer,, and M. C. Healey. 1999. A role for host phosphoinositide 3-kinase and cytoske1etal remodeling during Cryptosporidium parvum infection. Infect. Immun. 67: 844 852.
21. Genta, R. M.,, C. L. Chappell,, A. C. White, Jr.,, K. T. Kimball,, and R. W. Goodgame. 1993. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 105: 1769 1775.
22. Goldstein, S. T.,, D. D. Juranek,, O. Ravenholt,, A. W. Hightower,, D. G. Martin,, J. L. Mesnik,, S. D. Griffiths,, A. J. Bryant,, R. R. Reich,, and B. L. Herwaldt. 1996. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann. Intern. Med. 124: 459 468. (Erratum, 125: 158.)
23. Gomez Morales, M. A.,, G. La Rosa,, A. Ludovisi,, A. M. Onori,, and E. Pozio. 1999. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J. Infect. Dis. 179: 967 973.
24. Goodgame, R. W.,, K. Kimball,, C. N. Ou,, A. C. White, Jr.,, R. M. Genta,, C. H. Lifschitz,, and C. L. Chappell. 1995. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 108: 1075 1082.
25. Griffiths, J. K.,, R. Moore,, S. Dooley,, G. T. Keusch,, and S. Tzipori. 1994. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect. Immun. 62: 4506 4514.
26. Guerrant, D. I.,, S. R. Moore,, A. A. Lima,, P. D. Patrick,, J. B. Schorling,, and R. L. Guerrant. 1999. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four to seven years later in a poor urban community in northeast Brazil. Am. J. Trop. Med. Hyg. 61: 707 713.
27. Hashmey, R.,, N. H. Smith,, S. Cron,, E. A. Graviss,, C. L. Chappell,, and A. C. White, Jr. 1997. Cryptosporidiosis in Houston, Texas: a report of 95 cases. Medicine (Baltimore) 76: 118 139.
28. Holmberg, S. D.,, A. C. Moorman,, J. C. Von BargeD,, F. J. Palella,, M. O. Loveless,, D. J. Ward,, and T. R. Navin. 1998. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. JAMA 279: 384 386.
29. Laurent, F.,, L. Eckmann,, T. C. Savidge,, G. Morgan,, C. Theodos,, M. Naciri,, and M. F. Kagnoff. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65: 5067 5073.
30. Laurent, F.,, M. F. Kagnoff,, T. C. Savidge,, M. Naciri,, and L. Eckmann. 1998. Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin ~ and F1alpha production. Infect. Immun. 66: 1787 1790.
31. LeChevallier, M. W.,, W. D. Norton,, and R. G. Lee. 1991. Giardia and Cryptosporidium spp. in filtered drinking water supplies. Appl. Environ. Microbiol. 57: 2617 2621.
32. LeChevaltier, M. W.,, W. D. Norton,, and R. G. Lee. 1991. Occurrence of Giardia and Cryptosporidium spp. in surface water supplies. Appl. Environ. Microbiol. 57: 2610 2616. (Erratum, 58: 780, 1992).
33. Lumadue, J. A.,, Y. C. Manabe,, R. D. Moore,, P. C. Belitsos,, C. L. Sears,, and D. P. Clark. 1998. A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS 12: 2459 2466.
34. MacKenzie, W. R.,, N. J. Hoxie,, M. E. Proctor,, M. S. Gradus,, K. A. Blair,, D. E. Peterson,, J. J. Kazmierczak,, D. G. Addiss,, K. R. Fox,, and J. B. Rose. 1994. A massive outbreak: in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 331: 161 167. (Erratum, 331: 1035.)
35. MacKenzie, W. R.,, W. L. Schell,, K. A. Blair,, D. G. Addiss,, D. E. Peterson,, N. J. Hoxie,, J. J. Kazmierczak,, and J. P. Davis. 1995. Massive outbreak: of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin. Infect. Dis. 21: 57 62.
36. Manabe, Y. C.,, D. P. Clark,, R. D. Moore,, J. A. Lumadue,, H. R. Dahlman,, P. C. Belitsos,, R. E. Chaisson,, and C. L. Sears. 1998. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin. Infect. Dis. 27: 536 542.
37. McGowan, I.,, A. S. Hawkins,, and I. V. Weller. 1993. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 7: 349 354.
38. McLauchlin, J.,, S. Pedraza-Diaz,, C. Amar-Hoetzeneder,, and G. L. Nichols. 1999. Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J. Clin. Microbiol. 37: 3153 3158.
39. Meisel, J. L.,, D. R. Perera,, C. Meligro,, and C. E. Rubin. 1976. Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology 70: 1156 1160.
40. Molbak, K.,, N. Hojlyng,, A. Gottschau,, J. C. Sa,, L. Ingholt,, A. P. da Silva,, and P. Aaby. 1993. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. Br. Med. J. 307: 417 420.
41. Newman, R. D.,, C. L. Sears,, S. R. Moore,, J. P. Nataro,, T. Wumb,, D. A. Agnew,, R. L. Guerrant,, and A. A. Lima. 1999. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil J. Infect. Dis. 180: 167 175.
42. Newman, R. D.,, S. X. Zu,, T. Wuhib,, A. A. Lima,, R. L. Guerrant,, and C. L. Sears. 1994. Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann. Intern. Med. 120: 500 505.
43. Nime, F. A.,, J. D. Burek,, D. L. Page,, M. A. Holscher,, and J. H. Yardley. 1976. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 70: 592 598.
44. Okhuysen, P. C.,, C. L. Chappell,, J. H. Crabb,, C. R. Sterling,, and H. L. DuPont. 1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180: 1275 1281.
45. Okhuysen, P. C.,, C. L. Chappell,, C. R. Sterling,, W. Jakubowski,, and H. L. DuPont. 1998. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect. Immun. 66: 441 443.
46. Peng, M. M.,, L. Xiao,, A. R. Freeman,, M. J. Arrowood,, A. A. Esca1ante,, A. C. Weltman,, C. S. Ong,, W. R. Mac Kenzie,, A. A. Lal,, and C. B. Beard. 1997. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg. Infect. Dis. 3: 567 573.
47. Perkins, M. E.,, Y. A. Riojas,, T. W. Wu,, and S. M. Le Blancq. 1999. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc. Natl. Acad. Sci. USA 96: 5734 5739.
48. Perkins, M. E.,, T. W. Wu,, and S. M. Le Blancq. 1998. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum. Antimicrob. Agents Chemother. 42: 843 848.
49.Pozio, E , G. Rezza, A. Boscmni, P. Pezzotti, A. Tamburrini, P. Rossi, M. Di Fine, C. Smacchia, A. Schiesari, E. Gattei, R. Zucconi, and P. Ballarini. 1997. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J. Infect. Dis. 176: 969975.
50. Rossignol, J. F.,, H. Hidalgo,, M. Feregrino,, F. Higuera,, W. H. Gomez,, J. L. Romero,, J. Padiema,, A. Geyne,, and M. S. Ayers. 1998. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans. R. Soc. Trop. Med. Hyg. 92: 663 666.
51. Sears, C. L.,, and J. B. Kaper. 1996. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbial. Rev. 60: 167 215.
52. Seydel, K. B.,, T. Zhang,, G. A. Champion,, C. Fichtenbaum,, P. E. Swanson,, S. Tzipori,, J. K. Griffiths,, and S. L. Stanley, Jr. 1998. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect. Immun. 66: 2379 2382.
53. Smith, N. H.,, S. Cron,, L. M. Valdez,, C. L. Chappell,, and A. C. White, Jr. 1998. Combination drug therapy for cryptosporidiosis in AIDS. J. Infect. Dis. 178: 900 903.
54. Spano, F.,, L. Putignani,, A. Crisanti,, P. Sallicandro,, U. M. Morgan,, S. M. Le Blancq,, L. Tcback,, S. Tzipori,, and G. Widmer. 1998. Multilocus genotypic analysis of Cryptosporidium parvum isolates from different hosts and geographical origins. J. Clin. Microbiol. 36: 3255 3259.
55. Steiner, T. S.,, N. M. Thielman,, and R. L. Guerrant. 1997. Protozoal agents: what are the dangers for the public water supply? Annu. Rev. Med. 48: 329 340.
56. Tarver, A. P.,, D. P. Clark,, G. Diamond,, J. P. Russell,, H. Erdjument-Bromage,, P. Tempst,, K. S. Cohen,, D. E. Jones,, R. W. Sweeney,, M. Wines,, S. Hwang,, and C. L. Bevins. 1998. Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 66: 1045 1056. (Erratum, 66: 2399.)
57. Theodos, C. M.,, J. K. Griffiths,, J. D'Onfro,, A. Fairfield,, and S. Tzipori. 1998. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 42: 1959 1965.
58. Theodos, C. M.,, K. L. Sullivan,, J. K. Griffiths,, and S. Tzipori. 1997. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BLl6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect. Immun. 65: 4761 4769.
59. Tzipori, S.,, and J. K. Griffiths. 1998. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40: 5 36.
60. Vakil, N. B.,, S. M. Schwartz,, B. P. Buggy,, C. F. Brummitt,, M. Kherellah,, D. M. Letzer,, I. H. Gilson,, and P. G. Jones. 1996. Biliary cryptosporidiosis in HlV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N. Engl. J. Med. 334: 19 23.
61. White, A. C., Jr.,, P. Robinson,, P. C. Okhuysen,, D. E. Lewis,, L. Shahab,, S. Lahoti,, H. L. DuPont,, and C. L. Chappell. 2000. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J. Infect.Dis. 181: 701 709.
62. White, A. C., Jr.,, C. L. Chappell,, C. S. Hayat,, K. T. Kimball,, T. P. Flanigan,, and R. W. Goodgame. 1994. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J. Infect. Dis. 170: 419 424.
63. Widmer, G.,, S. Tzipori,, C. J. Fichtenbaum,, and J. K. Griffiths. 1998. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J. Infect. Dis. 178: 834 840.
64. Wyatt, C. R.,, E. J. Brackett,, L. E. Perryman,, A. C. Rice-Ficht,, W. C. Brown,, and K. I. O'Rourke. 1997. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum. Infect. Immun. 65: 185 190.
65. Xiao, L.,, U. M. Morgan,, J. Limor,, A. Escalante,, M. Arrowood,, W. Shulaw,, R. C. Thompson,, R. Fayer,, and A. A. Lal. 1999. Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl. Environ. Microbiol. 65: 3386 3391.

Tables

Generic image for table
Table 1.

a very infectious parasite

Citation: Sears C. 2000. Cryptosporidium parvum: Minuscule but Mighty, p 149-163. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 4. ASM Press, Washington, DC. doi: 10.1128/9781555816971.ch11

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error